Literature DB >> 36190691

Can the Imbalance between Neurotrophic and Apoptotic Proteins Be the "Beware the Ides of March" for Unaffected Relatives of Schizophrenia Patients?

Umit Haluk Yesilkaya1,2, Sakir Gica3, Pelin Ozkara Menekseoglu4, Busra Guney Tasdemir4, Zeynep Cirakli5, Nesrin Karamustafalioglu4.   

Abstract

Schizophrenia (SZ) is a mental disorder with a strong genetic basis as well as epigenetic aspects. Siblings of patients with SZ can share certain endophenotypes with the patients, suggesting that siblings may be important for distinguishing between trait and state markers. In the current study, we aimed to characterize the balance between pro-BDNF/mature BDNF and its receptors p75NTR/TrkB, which are tPA-BDNF pathways proteins and are thought to play a role in synaptic pruning, as a possible endophenotype of schizophrenia. Forty drug-naïve patients with first-episode psychosis (FEP) matched for age, gender, and level of education, 40 unaffected siblings (UAS) of patients with FEP, and 67 healthy controls (HC) were included in the study. Blood samples were collected from all participants to determine BDNF, pro-BDNF, TrkB and p75NTR, PAI1, tPA, ACTH, and cortisol levels. We showed that levels of proteins of the tPA-BDNF pathway as well as the pro-BDNF/m-BDNF and p75NTR/TrkB ratios could successfully differentiate FEP and their siblings from the HCs by using ROC analysis. Plasma levels of m-BDNF were found to be the lowest in the healthy siblings and highest in the HCs with statistically significant differences between all 3 groups. The plasma level of pro-BDNF in the HC group was similar to the FEP patients, the same in the healthy siblings of the FEP patients. Our data support the hypothesis that imbalance between neurotrophic and apoptotic proteins might occur in SZ and this imbalance could be an endophenotype of the disease.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; BDNF; Endophenotype; Neurotrophin; Schizophrenia; Synaptic pruning

Year:  2022        PMID: 36190691     DOI: 10.1007/s12035-022-03054-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  10 in total

1.  Role of tissue plasminogen activator and plasminogen activator inhibitor as potential biomarkers in psychosis.

Authors:  Sarah Elmi; Geetanjali Sahu; Kishor Malavade; Theresa Jacob
Journal:  Asian J Psychiatr       Date:  2019-05-13

Review 2.  The role of BDNF in the pathophysiology and treatment of schizophrenia.

Authors:  Gabriela Favalli; Jennifer Li; Paulo Belmonte-de-Abreu; Albert H C Wong; Zafiris Jeffrey Daskalakis
Journal:  J Psychiatr Res       Date:  2011-10-26       Impact factor: 4.791

3.  A Longitudinal Study of Serum Brain-Derived Neurotrophic Factor Levels in First-Episode Schizophrenia.

Authors:  Jie Yin Yee; Tih-Shih Lee; Jimmy Lee
Journal:  J Clin Psychopharmacol       Date:  2019 Nov/Dec       Impact factor: 3.153

4.  Role of pro-brain-derived neurotrophic factor (proBDNF) to mature BDNF conversion in activity-dependent competition at developing neuromuscular synapses.

Authors:  H Shawn Je; Feng Yang; Yuanyuan Ji; Guhan Nagappan; Barbara L Hempstead; Bai Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

5.  Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study.

Authors:  D Sun; G W Stuart; M Jenkinson; S J Wood; P D McGorry; D Velakoulis; T G M van Erp; P M Thompson; A W Toga; D J Smith; T D Cannon; C Pantelis
Journal:  Mol Psychiatry       Date:  2008-07-08       Impact factor: 15.992

Review 6.  A family affair: brain abnormalities in siblings of patients with schizophrenia.

Authors:  Marcel E Moran; Hilleke Hulshoff Pol; Nitin Gogtay
Journal:  Brain       Date:  2013-05-22       Impact factor: 13.501

Review 7.  BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity.

Authors:  Przemysław Kowiański; Grażyna Lietzau; Ewelina Czuba; Monika Waśkow; Aleksandra Steliga; Janusz Moryś
Journal:  Cell Mol Neurobiol       Date:  2017-06-16       Impact factor: 5.046

Review 8.  Synaptic Elimination in Neurological Disorders.

Authors:  Pablo L Cardozo; Izabella B Q de Lima; Esther M A Maciel; Nathália C Silva; Tomas Dobransky; Fabíola M Ribeiro
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

Review 9.  Schizophrenia.

Authors:  Michael J Owen; Akira Sawa; Preben B Mortensen
Journal:  Lancet       Date:  2016-01-15       Impact factor: 79.321

Review 10.  Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator.

Authors:  Silvia Hoirisch-Clapauch; Antonio E Nardi
Journal:  Int J Mol Sci       Date:  2015-11-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.